MIAMI, Aug. 07, 2018 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Progressive Care Inc. (OTCQB:RXMD), please note in the third paragraph the question submission deadline should be August 13, 2018, not May 14, 2018 as previously stated. The corrected release follows:
Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that the company will host a conference call on Tuesday, Aug. 14, 2018, at 4:30 PM ET to discuss financial results for the second quarter of 2018. Progressive Care management will also provide an update on the company’s recent progress and upcoming milestones.
“We have had a lot of exciting updates and news over the last three months,” said S. Parikh Mars, CEO of Progressive Care Inc. “As always, we feel that it is important to continue broadcasting our positive results and keep our investors informed on the company’s developments. We look forward to these quarterly calls and having the opportunity to address specific questions from investors and shareholders.”
Company shareholders, investors and other interested parties will also have the opportunity to submit company-related questions prior to the call to Stuart Smith at SmallCapVoice.Com, Inc. via email: email@example.com. Questions must be submitted by 3:00 PM ET on Monday, August 13, 2018. Prior to the conference call, Smith will compile and share all questions with Progressive Care for final consideration. Questions selected to be included in the conference call will be based on relevance to the shareholder base and appropriateness, considering public disclosure rules.
Interested parties can access the Q2 2018 investor call by using the provided dial-in details below:
Dial-In Number: (857) 232-0157
Access Code: 422095
For those unable to participate in the live conference call, a replay will be made available at https://smallcapvoice.com/rxmd/ shortly after the call has concluded. An archived version of the webcast will also be available at https://progressivecareus.com/investor/.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.